CSPC PHARMACEUTICAL GROUP LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of 1093 for the last semiannual is 16.60 B HKD, and it's 8.70% lower compared to the previous semiannual. The net income of H2 23 is 3.14 B HKD.